Liposomes to target the lymphatics by subcutaneous administration.
about
Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancerEmerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsRecent advances in lymphatic targeted drug delivery system for tumor metastasisActivation of latent HIV using drug-loaded nanoparticlesAntibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice.Theranostic mRNA-loaded microbubbles in the lymphatics of dogs: implications for drug delivery.Targeted Delivery of Immunomodulators to Lymph Nodes.Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.Simultaneous sentinel lymph node computed tomography and locoregional chemotherapy for lymph node metastasis in rabbit using an iodine-docetaxel emulsion.Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes.Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapiesRadiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides.Post-lumpectomy intracavitary retention and lymph node targeting of (⁹⁹m)Tc-encapsulated liposomes in nude rats with breast cancer xenograft.Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects.Nanoparticle migration and delivery of Paclitaxel to regional lymph nodes in a large animal modelAptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymph nodes with metastatic tumors.A Novel Loading Method for Doxycycline Liposomes for Intracellular Drug Delivery: Characterization of In Vitro and In Vivo Release Kinetics and Efficacy in a J774A.1 Cell Line Model of Mycobacterium smegmatis InfectionRapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity.Mechanistic determinants of biotherapeutics absorption following SC administration.Near infrared fluorescent chlorophyll nanoscale liposomes for sentinel lymph node mapping.Quantitative imaging of lymphatic function with liposomal indocyanine greenFeasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomesSolid Lipid Nanoparticles (SLNs) for Intracellular Targeting ApplicationsCoencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c miceInduction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination constructClinical applications of virosomes in cancer immunotherapy.Lymphatic biodistribution of polylactide nanoparticles.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.Innovative strategies for co-delivering antigens and CpG oligonucleotides.Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.A novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomesConvective diffusion of nanoparticles from the epithelial barrier toward regional lymph nodesIntradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice.Impact of molecular weight on lymphatic drainage of a biopolymer-based imaging agentA novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo.Inflammatory cytokines presented from polymer matrices differentially generate and activate DCs in situ.Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systemsMagnetoliposomes and their potential in the intelligent drug-delivery field.Nanopharmaceuticals to target antifilarials: a comprehensive review.Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
P2860
Q24806446-5E1452E0-B2DE-41EB-B7E0-3AC7CAF30C40Q26996159-5FB22506-A208-4ADF-A060-11807C84D391Q27005580-F97EEDAA-E166-4F5F-85DD-53FF1CC6E4EFQ28477657-D07BA216-F969-49B4-93C7-94F52BD931D5Q30397437-E0ABBBF1-CDFF-40D6-988F-30B267A491D9Q30422136-55292FF1-C128-4B42-A6B4-2D887ABDA15AQ30794718-E042C34B-17EF-4805-8443-E48CABBE7CB2Q30880102-9B0E8C89-98F9-419A-86CA-D2D6BE6179A4Q33688976-21A2E663-350F-4E03-80AD-223D6D96EC02Q34544095-CE0FD10F-7909-47A7-BDF5-E91187FB9E57Q35009191-99D10ECE-A04B-4C0C-AC25-62E1200DD2E9Q35202977-742C4CDB-5C09-48DC-9A60-56054B9190A4Q35249333-F478D3D4-1841-42C2-857B-B0DB12E05880Q35763466-5D4A49B5-B9DD-451F-9A24-A40D5981AC65Q35785838-FF5D1C63-6CDF-4325-8362-DF61FF95112FQ35800936-5506475C-9CA0-48D0-903C-375EDEE78158Q35897773-B42CC413-D48C-4547-B7BF-02AE6AFF0976Q35983565-90564EA2-F24C-4E15-B626-018657DF93BAQ36065572-E8FD1765-A3F1-4248-B428-A33EAFB0B584Q36079928-B70E89A1-1761-4D08-9308-AF1AA5D3A36DQ36098607-833F88C7-5404-4C18-BB31-056323480E36Q36239594-B166D041-E59F-4744-B1DA-FADED1F46E7FQ36408352-ADD0048E-809A-4E4C-A374-0B2CD38556CBQ36539044-54AC4B78-F1D5-4BA9-A52C-CE4A111653E4Q36616720-9F81FAD8-BA64-4EE2-B457-C33067D0CA4DQ36627236-7DB72553-1BA2-49BE-BFB0-3311FD6266B1Q36975890-A30761CA-E0D5-426D-AF3A-C99CA258A33AQ37066550-3D273EF2-ACA4-4A25-802E-7278AC240612Q37130626-8E3C8B28-6009-4F70-8F08-E91BEF7FF706Q37142202-14B6CA17-EEE3-4104-80F5-C4638EBC5565Q37232138-556CE284-E32A-4F16-AD01-4FB2951C5A64Q37244096-79A9DB83-D980-472A-8135-5ED4D20A0EDFQ37290106-AE30195F-027F-4CFD-88F9-B2811273F0CAQ37327825-2FAE4BE2-6CDC-46BD-9BD1-A3F6ED034C67Q37470083-4A0DA505-C34E-4EDF-880E-FF8C85C30AFCQ37670964-3C620829-C7B3-4F7B-9738-7ED91EEEF25AQ37942472-83588A77-C82F-453B-81C4-7B1DDBBA6116Q38074445-38C073BB-C2C8-42B1-968B-057E09178F0AQ38083301-1D7503B0-D9E7-4611-ACF0-97B69C4928FBQ38151736-E373EA59-9757-40D1-9136-897A1F9EDEE9
P2860
Liposomes to target the lymphatics by subcutaneous administration.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Liposomes to target the lymphatics by subcutaneous administration.
@ast
Liposomes to target the lymphatics by subcutaneous administration.
@en
Liposomes to target the lymphatics by subcutaneous administration.
@nl
type
label
Liposomes to target the lymphatics by subcutaneous administration.
@ast
Liposomes to target the lymphatics by subcutaneous administration.
@en
Liposomes to target the lymphatics by subcutaneous administration.
@nl
prefLabel
Liposomes to target the lymphatics by subcutaneous administration.
@ast
Liposomes to target the lymphatics by subcutaneous administration.
@en
Liposomes to target the lymphatics by subcutaneous administration.
@nl
P1476
Liposomes to target the lymphatics by subcutaneous administration.
@en
P2093
P304
P356
10.1016/S0169-409X(01)00154-5
P407
P577
2001-08-01T00:00:00Z